Curio Wealth’s NovoCure NVCR Stock Holding History

Curio Wealth’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-15	Closed	-$164	–	788
2026 Q1	$164	Hold	15	–	–	﹤0.01%	850
2025 Q4	$202	Buy	+15	New	+$193	﹤0.01%	426
2025 Q3	–	Sell	-15	Closed	-$267	–	340
2025 Q2	$267	Buy	15 +14	+1,400%	+$244	﹤0.01%	326
2025 Q1	$447	Buy	+1	New	+$23	﹤0.01%	342

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Curio Wealth's NVCR Position: Q2 2026 in Review

Curio Wealth sold out of NovoCure (NVCR) in Q2 2026, closing a stake of 15 shares — an estimated $164 sold.

Curio Wealth first reported a position in NVCR in Q1 2025 and held it in 4 quarters. The position peaked at $447 in Q1 2025. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

Curio Wealth reported no remaining NovoCure position as of Q2 2026 after selling out during the quarter.
Curio Wealth sold 15 NovoCure shares in Q2 2026, an estimated $164.
Curio Wealth first reported a position in NovoCure in Q1 2025 and held it in 4 quarters.
Curio Wealth's NovoCure position peaked at $447 in Q1 2025.
218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Curio Wealth's 13F filing for Q2 2026, filed 7 Aug 2026.